dpiresearch.com-Global Influenza Vaccines Market and Forecasts 2024 2032

1. Global Influenza Vaccines Market and Forecasts 2024 – 2032 dpiresearch.com/report/global-influenza-vaccines-market-2024/ 1/6

2. ( $2,450 – $3,500 Download Free Sample Content Info : 310 pages Published Date: January, 2024 Publisher: DPI Research Region: Global Unique Offerings from DPI Research Right People Right Methodology Best Support Best Price Guaranteed Safe Checkout The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period. Several factors are contributing to the growth of the influenza vaccines market. Here are some key factors: Increasing Awareness and Education Government Initiatives and Vaccination Programs Rising Incidence of Influenza Advancements in Vaccine Technology 2/6

3. Increased Healthcare Spending Expanding Target Population Globalization and Travel Growing Geriatric Population Public Health Preparedness Collaborations and Partnerships Regulatory Support “Global Influenza Vaccines Market and Forecasts 2024 – 2032” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global influenza vaccines market. The report also provides up-to-date historical market size data for the period 2018 – 2023 and an illustrative forecast to 2032 covering key market aspects like market value, volume analysis, and trends for influenza vaccines globally. The report contains a deep analysis of the global influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the children and adults vaccinated with influenza vaccines globally from 2018 – 2023 and forecasts to 2032. It provides essential insights into influenza vaccines market revenue for the top 27 regional and national, and forecast until 2032. Key trends in terms of collaboration deals, merger & acquisitions, distribution, exclusive and licensing agreement are analyzed with details. The report also offers detailed information about the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase. The report also investigates detailed insights about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU, and Japan. The report also delivers a detailed assessment of the latest happenings in the influenza vaccines market globally. The report also examines the main market growth driving and challenges forces and also gives an all-round future outlook through 2032. The report concludes with the profiles of the key players in the global influenza vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, influenza vaccines sales value analysis, and recent development. Other emerging players are making novel technology-based vaccines that are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology, and recent development. The report will serve as a source for a 360-degree analysis in which various models will be thoroughly integrated. After a thorough study of the historical and current growth parameters, the growth prospects of the global influenza vaccines market are determined with utmost precision. Key and Emerging Players in the Global Influenza Vaccines Market are Listed Below: 1. Sanofi Pasteur 3/6

4. 2. GlaxoSmithKline (GSK) 3. Seqirus (CSL Limited) 4. AstraZeneca 5. Mylan(Viatris) 6. BioDiem 7. Novavax 8. Medicago 9. Moderna Inc 10. Pneumagen 11. Daiichi–Sankyo 12. Altimmune 13. FluGen 14. Imutex 15. EpiVax 16. Osivax 17. Emergex Vaccines 18. Versatope Therapeutics, Inc. 19. BIKEN Co., Ltd. 20. Gamma Vaccines Pty Ltd. 21. BiondVax Pharmaceuticals Ltd. 22. Hualan Biological Engineering Inc. 23. Shanghai Institute of Biological Products Co., Ltd. The Report Analyses the Market on the Basis of Nationals and Presents the Forecast in Terms of Value and Volume for the Next 8 Years. Twenty-Seven Major Markets(27MM) Covered in the Report are as follows: 1. United States 2. Canada 3. Brazil 4. Germany 5. France 6. Italy 7. Spain 8. United Kingdom 9. Netherlands 10. Sweden 11. Denmark 12. Poland 13. Norway 14. Finland 15. Ireland 16. Belgium 17. Australia 18. New Zealand 19. Japan 4/6

5. 20. China 21. India 22. South Korea 23. Thailand 24. Singapore 25. Hongkong 26. Malaysia 27. Indonesia This Latest and Comprehensive the Global Influenza Vaccines Market Research Report 2024 provides: Comprehensive research methodology of the global influenza vaccines market Detailed and comprehensive market overview with important analyst insights Insights into the market determinants stimulating the global influenza vaccines market Analysis of the historical growth of the market size of the global influenza vaccines market from 2018 to 2023 Global influenza vaccines market size estimation and forecast from 2024 to 2032 and growth rate up to 2032 The market size of the 27 major influenza vaccines markets with eight years forecast High-Level Assessment of the Overall Persons Being Vaccinated with Influenza Vaccines Scrutinizes the Persons Being Vaccinated with Influenza Vaccines in the 27 major influenza vaccines markets with eight years forecast Detailed assessment of the Most Recent Happenings in the Global Influenza Vaccines Market Comprehensive analysis of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing Agreement Detailed Observations of the Most Recent Clinical Trials of the Influenza Vaccines A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development This 2024 Report Helps Answer the Following Questions: What is the current size of the global influenza vaccines market? How big is the global market for influenza vaccines? How much will this market be worth between 2024 and 2032? How many persons being vaccinated with influenza vaccines globally during 2018 – 2032? Which country is the leader in the global market for influenza vaccines? How large is the market and what are the growth rates of the 27 most important markets for influenza vaccines? What is the regulatory framework of the global influenza vaccines market? What are the main drivers and challenges in the global influenza vaccines market? What are the major deals happenings in the global influenza vaccines market? 5/6

6. Who are the top players and what are their activities, revenue, recent developments, and prospects? Who are the emerging players? What are some of the most prominent influenza vaccines currently in development? What are the activities, phase, platform technology, and recent developments of the emerging players? How will the industry develop in the forecast period 2024 – 2032? 6/6